BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Triposkiadis FK, Skoularigis J. Prevalence and Importance of Comorbidities in Patients With Heart Failure. Curr Heart Fail Rep 2012;9:354-62. [DOI: 10.1007/s11897-012-0110-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Schoemaker RG, Eisel UL. Cross Talk Between Brain and Inflammation. Inflammation in Heart Failure. Elsevier; 2015. pp. 81-91. [DOI: 10.1016/b978-0-12-800039-7.00005-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 González-Moneo MJ, Sánchez-Benavides G, Verdu-Rotellar JM, Cladellas M, Bruguera J, Quiñones-Ubeda S, Enjuanes C, Peña-Casanova J, Comín-Colet J. Ischemic aetiology, self-reported frailty, and gender with respect to cognitive impairment in chronic heart failure patients. BMC Cardiovasc Disord 2016;16:163. [PMID: 27577747 DOI: 10.1186/s12872-016-0349-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
3 Omersa D, Lainscak M, Erzen I, Farkas J. Mortality and readmissions in heart failure: an analysis of 36,824 elderly patients from the Slovenian national hospitalization database. Wien Klin Wochenschr 2016;128:512-8. [DOI: 10.1007/s00508-016-1098-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
4 Khan MS, Samman Tahhan A, Vaduganathan M, Greene SJ, Alrohaibani A, Anker SD, Vardeny O, Fonarow GC, Butler J. Trends in prevalence of comorbidities in heart failure clinical trials. Eur J Heart Fail 2020;22:1032-42. [PMID: 32293090 DOI: 10.1002/ejhf.1818] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
5 Bencivenga L, Komici K, Femminella GD, Paolillo S, Gargiulo P, Formisano R, Assante R, Nappi C, Puzone B, Sepe I, Cittadini A, Vitale DF, Ferrara N, Cuocolo A, Filardi PP, Rengo G. Impact of the number of comorbidities on cardiac sympathetic derangement in patients with reduced ejection fraction heart failure. Eur J Intern Med 2021;86:86-90. [PMID: 33485737 DOI: 10.1016/j.ejim.2021.01.010] [Reference Citation Analysis]
6 Adoubi KA, Soya E, Bamba KD, Koffi F, N'Cho-Mottoh MP, Diby F, Gnaba A, Konin C. [Burden of comorbidities in heart failure patients hospitalized at the Abidjan Heart Institute]. Ann Cardiol Angeiol (Paris) 2020;69:74-80. [PMID: 32223908 DOI: 10.1016/j.ancard.2020.03.002] [Reference Citation Analysis]
7 Naudé PJ, Mommersteeg PM, Zijlstra WP, Gouweleeuw L, Kupper N, Eisel UL, Kop WJ, Schoemaker RG. Neutrophil Gelatinase-Associated Lipocalin and depression in patients with chronic heart failure. Brain, Behavior, and Immunity 2014;38:59-65. [DOI: 10.1016/j.bbi.2013.12.023] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
8 Schmidt M, Ulrichsen SP, Pedersen L, Bøtker HE, Sørensen HT. Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study: Heart failure hospitalization, outcome, and co-morbidity. Eur J Heart Fail 2016;18:490-9. [DOI: 10.1002/ejhf.486] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 16.3] [Reference Citation Analysis]
9 Rosen D, Berrios-Thomas S, Engel RJ. Increasing self-knowledge: Utilizing tele-coaching for patients with congestive heart failure. Soc Work Health Care 2016;55:711-9. [PMID: 27348634 DOI: 10.1080/00981389.2016.1191581] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
10 Aljohar A, Alhabib KF, Kashour T, Hersi A, Al Habeeb W, Ullah A, Elasfar A, Almasood A, Ghabashi A, Mimish L, Alghamdi S, Abuosa A, Malik A, Hussein GA, Al-Murayeh M, AlFaleh H. The prognostic impact of hyperglycemia on clinical outcomes of acute heart failure: Insights from the heart function assessment registry trial in Saudi Arabia. J Saudi Heart Assoc 2018;30:319-27. [PMID: 30072842 DOI: 10.1016/j.jsha.2018.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Khan MS, Samman Tahhan A, Vaduganathan M, Greene SJ, Alrohaibani A, Anker SD, Vardeny O, Fonarow GC, Butler J. Trends in prevalence of comorbidities in heart failure clinical trials. Eur J Heart Fail 2020;22:1032-42. [PMID: 32293090 DOI: 10.1002/ejhf.1818] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Sakamoto R, Koyama A. Fentanyl Infusion Is Effective in the Treatment of Dyspnea in End-Stage Heart Failure With Renal Failure: A Case Report. Cureus 2021;13:e12673. [PMID: 33604211 DOI: 10.7759/cureus.12673] [Reference Citation Analysis]
13 Torday JS. Pleiotropy as the Mechanism for Evolving Novelty: Same Signal, Different Result. Biology (Basel) 2015;4:443-59. [PMID: 26103090 DOI: 10.3390/biology4020443] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
14 Sicras Mainar A, Navarro Artieda R, Ibáñez Nolla J. Impacto económico de la insuficiencia cardiaca según la influencia de la insuficiencia renal. Revista Española de Cardiología 2015;68:39-46. [DOI: 10.1016/j.recesp.2014.02.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
15 Roibal Pravio J, Barge Caballero E, Barbeito Caamaño C, Paniagua Martin MJ, Barge Caballero G, Couto Mallon D, Pardo Martinez P, Grille Cancela Z, Blanco Canosa P, García Pinilla JM, Vázquez Rodríguez JM, Crespo Leiro MG. Determinants of maximal oxygen uptake in patients with heart failure. ESC Heart Fail 2021;8:2002-8. [PMID: 33773098 DOI: 10.1002/ehf2.13275] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Gao WQ, Meng XD, Sun Z. Efficacy of tolvaptan for chronic heart failure: Study protocol for a systematic review of randomized controlled trial. Medicine (Baltimore) 2019;98:e14540. [PMID: 30762795 DOI: 10.1097/MD.0000000000014540] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Kessing D, Denollet J, Widdershoven J, Kupper N. Self-care and health-related quality of life in chronic heart failure: A longitudinal analysis. Eur J Cardiovasc Nurs 2017;16:605-13. [PMID: 28895482 DOI: 10.1177/1474515117702021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
18 Kim MS, Lee GH, Kim YM, Lee BW, Nam HY, Sim UC, Choo SJ, Yu SW, Kim JJ, Kim Kwon Y, Who Kim S. Angiotensin II Causes Apoptosis of Adult Hippocampal Neural Stem Cells and Memory Impairment Through the Action on AMPK-PGC1α Signaling in Heart Failure. Stem Cells Transl Med 2017;6:1491-503. [PMID: 28244243 DOI: 10.1002/sctm.16-0382] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
19 Stewart S, Riegel B, Boyd C, Ahamed Y, Thompson DR, Burrell LM, Carrington MJ, Coats A, Granger BB, Hides J, Weintraub WS, Moser DK, Dickson VV, McDermott CJ, Keates AK, Rich MW. Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement. Int J Cardiol 2016;212:1-10. [PMID: 27015641 DOI: 10.1016/j.ijcard.2016.03.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
20 Sicras Mainar A, Navarro Artieda R, Ibáñez Nolla J. Economic impact of heart failure according to the effects of kidney failure. Rev Esp Cardiol (Engl Ed) 2015;68:39-46. [PMID: 25553938 DOI: 10.1016/j.rec.2014.02.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
21 Lee CS, Chien CV, Bidwell JT, Gelow JM, Denfeld QE, Masterson Creber R, Buck HG, Mudd JO. Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample. BMC Cardiovasc Disord 2014;14:73. [PMID: 24898986 DOI: 10.1186/1471-2261-14-73] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
22 Song X, Roy B, Fonarow GC, Woo MA, Kumar R. Brain structural changes associated with aberrant functional responses to the Valsalva maneuver in heart failure. J Neurosci Res 2018;96:1610-22. [PMID: 30113721 DOI: 10.1002/jnr.24264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Deng AY. Genetics of diastolic heart failure. J Hypertens 2013;31:2329-36. [PMID: 24220586 DOI: 10.1097/HJH.0b013e328365662c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
24 Bakogiannis C, Tsarouchas A, Mouselimis D, Lazaridis C, Theofillogianakos EK, Billis A, Tzikas S, Fragakis N, Bamidis PD, Papadopoulos CE, Vassilikos VP. A Patient-Oriented App (ThessHF) to Improve Self-Care Quality in Heart Failure: From Evidence-Based Design to Pilot Study. JMIR Mhealth Uhealth 2021;9:e24271. [PMID: 33847599 DOI: 10.2196/24271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sabatino L, Iervasi G, Pingitore A. Thyroid hormone and heart failure: from myocardial protection to systemic regulation. Expert Rev Cardiovasc Ther 2014;12:1227-36. [PMID: 25220579 DOI: 10.1586/14779072.2014.957674] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
26 Stewart S, Riegel B, Thompson DR. Addressing the conundrum of multimorbidity in heart failure: Do we need a more strategic approach to improve health outcomes? Eur J Cardiovasc Nurs 2016;15:4-7. [PMID: 26362926 DOI: 10.1177/1474515115604794] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
27 Lane DA, Aguinaga L, Blomström-Lundqvist C, Boriani G, Dan GA, Hills MT, Hylek EM, LaHaye SA, Lip GY, Lobban T, Mandrola J, McCabe PJ, Pedersen SS, Pisters R, Stewart S, Wood K, Potpara TS, Gorenek B, Conti JB, Keegan R, Power S, Hendriks J, Ritter P, Calkins H, Violi F, Hurwitz J. Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace 2015;17:1747-69. [PMID: 26108807 DOI: 10.1093/europace/euv233] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 12.4] [Reference Citation Analysis]